- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 225/00 - Compounds containing amino groups and doubly-bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly-bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
Patent holdings for IPC class C07C 225/00
Total number of patents in this class: 32
10-year publication summary
|
1
|
1
|
0
|
2
|
1
|
0
|
2
|
2
|
1
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Glaxosmithkline LLC | 535 |
2 |
| Conopco, Inc. | 5003 |
2 |
| The Regents of the University of California | 20245 |
2 |
| DIC Corporation | 3838 |
2 |
| Johnson & Johnson Vision Care, Inc. | 1176 |
1 |
| Bayer Cropscience AG | 1996 |
1 |
| BASF Corporation | 1713 |
1 |
| Shin-Etsu Chemical Co., Ltd. | 5764 |
1 |
| The Board of Trustees of the Leland Stanford Junior University | 6522 |
1 |
| DSM IP Assets B.V. | 5567 |
1 |
| Ethicon, Inc. | 1161 |
1 |
| Brigham Young University | 600 |
1 |
| F.I.S. Fabbrica Italiana Sintetici S.p.A. | 131 |
1 |
| Georgetown University | 620 |
1 |
| Golden Biotechnology Corporation | 33 |
1 |
| KemPharm, Inc. | 28 |
1 |
| Northeastern University | 1215 |
1 |
| Orion Corporation | 691 |
1 |
| Pierre Fabre Medicament | 565 |
1 |
| Tranzyme Pharma, Inc. | 7 |
1 |
| Other owners | 8 |